However, as cancer cells may be dependent on other anti-apoptotic proteins due to their heterogeneity and phenotype/genotype plasticity, BH3-mimetics targeting the other prosurvival proteins BCL-xL or MCL-1 are also undergoing clinical investigation [43]. Here, BCL2L1 is linked to cancer.